【レポートの概要（一部）】
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Application Analysis
3.8 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Stem Cell Therapy Market, By Treatment
5.1 Introduction
5.2 Autologous stem cell therapy
5.2.1 CNS Diseases
5.2.2 Wounds and Injuries
5.2.3 CVS Diseases
5.2.4 Musculoskeletal Disorders
5.2.5 GIT Diseases
5.2.6 Other Diseases
5.3 Allogeneic stem cell therapy
5.3.1 CNS Diseases
5.3.2 Musculoskeletal Disorders
5.3.3 Wounds and Injuries
5.3.4 GIT diseases
5.3.5 Metabolic Diseases
5.3.6 Immune System Diseases
5.3.7 Eye Diseases
5.3.8 CVS Diseases
5.3.9 Other Diseases
6 Global Stem Cell Therapy Market, By End User
6.1 Introduction
6.2 Hospitals
6.3 Ambulatory Surgical centers
7 Global Stem Cell Therapy Market, By Application
7.1 Introduction
7.2 Cardiovascular diseases
7.3 Eye diseases
7.4 Metabolic diseases
7.5 Musculoskeletal disorders
7.6 Gastro intestine diseases
7.7 Central Nervous System diseases
7.8 Immune system diseases
7.9 Wounds and injuries
8.10 Other diseases
8 Global Stem Cell Therapy Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Aastrom Biosciences Inc.
10.2 Cellular Dynamics International Inc.
10.3 ReNeuron Group plc
10.4 Roslin Cells limited
10.5 Advanced Cell Technologies Inc.
10.6 Cytori Therapeutics Inc.
10.7 Celgene Corporation
10.8 Gamida Cell Ltd.
10.9 International Stem Cell Corporation
10.10 Mesoblast Ltd.
10.11 Pluristem Therapeutics Inc.
10.12 Fibrocell Science Inc.
10.13 Stemcells Inc.
10.14 Regeneus Ltd
10.15 Athersys Inc.
List of Tables
1 Global Stem Cell Therapy Market Outlook, By Region (2013-2022) ($MN)
2 Global Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
3 Global Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
4 Global Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
5 Global Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
6 Global Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
7 Global Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
8 Global Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
9 Global Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
10 Global Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
11 Global Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
12 Global Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
13 Global Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
14 Global Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
15 Global Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
16 Global Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
17 Global Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
18 Global Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
19 Global Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
20 Global Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
21 Global Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
22 Global Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
23 Global Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
24 Global Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
25 Global Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
26 Global Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
27 Global Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
28 Global Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
29 Global Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
30 Global Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
31 Global Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
32 Global Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
33 Global Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
34 North America Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
35 North America Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
36 North America Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
37 North America Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
38 North America Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
39 North America Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
40 North America Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
41 North America Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
42 North America Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
43 North America Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
44 North America Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
45 North America Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
46 North America Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
47 North America Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
48 North America Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
49 North America Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
50 North America Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
51 North America Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
52 North America Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
53 North America Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
54 North America Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
55 North America Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
56 North America Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
57 North America Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
58 North America Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
59 North America Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
60 North America Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
61 North America Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
62 North America Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
63 North America Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
64 North America Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
65 North America Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
66 North America Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
67 Europe Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
68 Europe Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
69 Europe Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
70 Europe Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
71 Europe Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
72 Europe Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
73 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
74 Europe Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
75 Europe Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
76 Europe Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
77 Europe Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
78 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
79 Europe Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
80 Europe Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
81 Europe Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
82 Europe Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
83 Europe Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
84 Europe Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
85 Europe Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
86 Europe Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
87 Europe Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
88 Europe Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
89 Europe Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
90 Europe Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
91 Europe Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
92 Europe Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
93 Europe Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
94 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
95 Europe Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
96 Europe Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
97 Europe Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
98 Europe Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
99 Europe Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
100 Asia Pacific Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
101 Asia Pacific Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
102 Asia Pacific Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
103 Asia Pacific Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
104 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
105 Asia Pacific Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
106 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
107 Asia Pacific Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
108 Asia Pacific Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
109 Asia Pacific Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
110 Asia Pacific Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
111 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
112 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
113 Asia Pacific Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
114 Asia Pacific Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
115 Asia Pacific Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
116 Asia Pacific Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
117 Asia Pacific Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
118 Asia Pacific Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
119 Asia Pacific Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
120 Asia Pacific Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
121 Asia Pacific Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
122 Asia Pacific Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
123 Asia Pacific Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
124 Asia Pacific Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
125 Asia Pacific Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
126 Asia Pacific Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
127 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
128 Asia Pacific Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
129 Asia Pacific Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
130 Asia Pacific Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
131 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
132 Asia Pacific Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
133 RoW Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
134 RoW Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
135 RoW Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
136 RoW Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
137 RoW Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
138 RoW Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
139 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
140 RoW Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
141 RoW Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
142 RoW Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
143 RoW Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
144 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
145 RoW Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
146 RoW Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
147 RoW Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
148 RoW Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
149 RoW Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
150 RoW Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
151 RoW Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
152 RoW Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
153 RoW Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
154 RoW Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
155 RoW Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
156 RoW Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
157 RoW Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
158 RoW Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
159 RoW Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
160 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
161 RoW Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
162 RoW Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
163 RoW Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
164 RoW Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
165 RoW Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
【レポート販売概要】
■ タイトル：幹細胞治療の世界市場：自己幹細胞治療、アロジェネイック幹細胞治療■ 英文：Stem Cell Therapy - Global Market Outlook (2015-2022)
■ 発行日：2016年5月11日
■ 調査会社：Stratistics MRC
■ 商品コード：SMRC60799
■ 調査対象地域：グローバル
- 神経因性疼痛：グローバル臨床試験レビュー（2014年上半期）Neuropathic Pain Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Neuropathic Pain Global Clinical Trials Review, H1, 2014" provides data on the Neuropathic Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuropathic Pain. It includes an overview of the trial numbers and their recruitment statu …
- 動力工具の世界市場予測（～2023年）：穴あけ工具、締結工具、鋸具、破壊工具、除去用工具“Power tools market to exhibit significant growth potentials between 2017 and 2023”The power tools market is expected to grow at a CAGR of 4.6% between 2017 and 2023, to reach USD 35.58 billion by 2023. The key driving factors for the growth of the market are the increasing urbanization, constant growth of the construction industry in emerging economies, increasing sales of commercial vehicles acr …
- 界面活性剤の世界市場予測（～2021年）：陰イオン界面活性剤、非イオン性界面活性剤、陽イオン界面活性剤、両性界面活性剤The surfactants market is estimated to reach USD 39.86 Billion, by 2021, from USD 30.64 Billion in 2016, at a CAGR of 5.4%, between 2016 and 2021. The growth of the surfactants market is primarily triggered by the rising demand from the personal care segment. Surfactants are widely used in detergents, cleaners, soaps, and shampoos other related products for removing dirt, oil, stains, and various …
- 世界の医薬品卸売及び流通市場：地域別分析、主要企業分析Trends and revenue potentials for distributing and wholesaling of medicines Where’s the drug wholesaler and distribution (W&D) market heading? Discover revenue predictions there to 2024. Also find trends in business and technology, assessing prospects and opportunities to help your work and benefit your influence. In visiongain’s new report you gain sales forecasts there at overall world market, s …
- 平ガラスの世界市場分析：製品別（強化、ラミネート、基本フロート、断熱）、用途別（自動車、建設）、セグメント予測Global Flat Glass market is expected to reach USD 124.14 billion by 2022, according to a new study by Grand View Research, Inc. Rising awareness regarding benefits of glass usage in building & construction including safety, security and energy savings is expected to drive flat glass market over the forecast period. Product innovations in terms of improved characteristics coupled with introduction …
- ACおよびDCアダプターの世界市場2016-2020About AC and DC Adapters An AC and DC adapter is a type of external power supply often enclosed in an AC plug. The adapter is also known as a plug pack, adapter block, line power adapter, domestic mains adapter, power adapter, and wall wart power brick. AC adapters are used to power electrical devices, which do not contain internal components, to derive the required voltage from the mains power. T …
- 世界の高度道路交通システム（ITS）市場（2014-2018）About Intelligent Transport Systems Intelligent transport systems are sophisticated applications that provide solutions for various modes of transport and traffic management. They allow commuters to be informed, safe, and save traveling time, as well as reduce the cost and increase the quality of the traffic management process. These systems are used for multiple applications, especially by govern …
- 世界の医療用クラウドコンピューティング市場：製品別（EMR / EHR、PACS、VNA、PHM、テレヘルス、RCM、CRM、不正管理）、サービス別（SaaS、IaaS）、展開別（プライベートクラウド、ハイブリッドクラウド）、価格別（現金払い）、コンポーネント別（ソフトウェア）“The global healthcare cloud computing market is projected to grow at a CAGR of 17.2% during the forecast period (2019–2024).” The global healthcare cloud computing market size is projected to reach USD 51.9 billion by 2024, from an estimated USD 23.4 billion in 2019 at a CAGR of 17.2% during the forecast period. The key factors driving the growth of this market include the increasing adoption of …
- ココアの世界市場：ココア液、ココア粉、ココアバターAbout Cocoa Cocoa is cultivated primarily in countries located in the belt between 10ºN and 10ºS of the equator on account of the favorable climatic conditions. The demand for cocoa is increasing rapidly with the growth of chocolate confectioneries and other end-products. Cocoa production is characterized by the presence of small-scale farmers who have limited access to finance and technology, as …
- タイミングベルトの世界市場予測（～2025年）：ドライベルト、チェーン、油中ベルト、遊び滑車、スプロケット、テンショナ、タイミング・シールド、カバー“The growth of direct injection engines and rise in vehicle production fuel the demand for the timing belt market”The timing belt market is estimated to grow at a CAGR of 5.21% during the forecast period, to reach a market size of USD 9.22 billion by 2025. The key factors driving the growth of the timing belt market are the rising adoption of direct injection engines and growing vehicle production …
- 世界の交通システム/ソリューション及び分析ツール市場About Transportation Systems and Analytics Globalization and hyper-urbanization have created the need for an efficient transportation system. Various advanced transportation systems and analytical tools help transportation agencies to make real-time decisions, improve operational efficiencies, and provide safe and secure services to customers. Since transportation systems comprise of a vast networ …
- ホットメルト接着剤（HMA）の世界市場予測（～2022年）：EVA、SBC、MPO、APAO、ポリアミド、ポリオレフィン、ポリウレタン“Growing use of Hot Melt Adhesives (HMAs) in packaging solutions and nonwoven hygiene products is a prime factor in the growth of the HMA market” The Hot Melt Adhesives (HMA) market is projected to grow from an estimated USD 6.92 billion in 2017 to USD 9.46 billion by 2022, at a CAGR of 6.5%. The growth of the market is due to the increasing HMA applications in packaging solutions and nonwoven hyg …
- 小児脂肪便症（セリアック病）治療薬の市場機会分析OpportunityAnalyzer: Celiac Disease - Opportunity Analysis and Forecast to 2023 Summary There are no pharmacological treatments that are indicated for celiac disease and the current standard of care treatment involves a gluten free diet (GFD). Steroids and immunosuppressants are used to reduce symptoms in severe cases, targeting approximately 5% of the celiac disease patient population and there a …
- 音楽シンセサイザの世界市場2016-2020About the Music Synthesizers Market The electric signals, in a synthesizer or synths, are converted to sound with the help of amplifiers and speakers. The instrument is mostly played in conjunction with a keyboard. It can also be controlled using musical instruments such as guitars, sequencers, drums, and fingerboards. Analog, digital, modular, and virtual synthesizers are some of the most popular …
- エピネフリン・オートインジェクターの世界市場2015-2019About Epinephrine Epinephrine, commonly known as adrenaline, is a hormone secreted by the medulla of the adrenal gland and circulated through the bloodstream. It acts as a neurotransmitter that responds to brain signals. These signals trigger responses such as threat, excitement, danger, emotion, and stress, which stimulate the adrenal gland to secrete epinephrine in response to the changes in the …
